Format
Sort by
Items per page

Send to

Choose Destination

Best matches for acquired immunodeficiency syndrome AND efavirenz AND hiv AND lipodystrophy:

Search results

Items: 7

1.

Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies.

Nolis T.

J Hum Genet. 2014 Jan;59(1):16-23. doi: 10.1038/jhg.2013.107. Epub 2013 Oct 24. Review.

PMID:
24152769
2.

Body changes: antiretroviral therapy and lipodystrophy syndrome in people living with HIV/AIDS.

Tsuda LC, da Silva MM, Machado AA, Fernandes AP.

Rev Lat Am Enfermagem. 2012 Sep-Oct;20(5):847-53. English, Portuguese, Spanish.

3.

Tenofovir: new indication. For first-line antiretroviral therapy: wait and see.

[No authors listed]

Prescrire Int. 2004 Oct;13(73):180-2.

PMID:
15499699
4.

Substitution of nevirapine, efavirenz, or abacavir for protease inhibitors in patients with human immunodeficiency virus infection.

Martínez E, Arnaiz JA, Podzamczer D, Dalmau D, Ribera E, Domingo P, Knobel H, Riera M, Pedrol E, Force L, Llibre JM, Segura F, Richart C, Cortés C, Javaloyas M, Aranda M, Cruceta A, de Lazzari E, Gatell JM; Nevirapine, Efavirenz, and Abacavir (NEFA) Study Team.

N Engl J Med. 2003 Sep 11;349(11):1036-46.

5.

Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.

McComsey G, Bhumbra N, Ma JF, Rathore M, Alvarez A; First Pediatric Switch Study.

Pediatrics. 2003 Mar;111(3):e275-81.

PMID:
12612284
6.
7.

[Lipodystrophy and antiretroviral agents].

Martínez E, Gatell JM.

Rev Clin Esp. 1999 Aug;199(8):485-6. Spanish. No abstract available.

PMID:
10522426

Supplemental Content

Loading ...
Support Center